|
KLF6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.05780000003719E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.74910000000561E-06 |
| Normal-vs-Stage2 |
7.42619999938299E-08 |
| Normal-vs-Stage3 |
6.12440000047343E-07 |
| Normal-vs-Stage4 |
4.20050000005112E-07 |
| Stage1-vs-Stage2 |
4.984200E-03 |
| Stage1-vs-Stage3 |
1.165230E-01 |
| Stage1-vs-Stage4 |
7.352200E-02 |
| Stage2-vs-Stage3 |
1.072950E-01 |
| Stage2-vs-Stage4 |
2.428200E-01 |
| Stage3-vs-Stage4 |
7.047400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.07590000003799E-06 |
| Normal-vs-AfricanAmerican |
1.86880999999417E-05 |
| Normal-vs-Asian |
6.91140000008694E-07 |
| Caucasian-vs-AfricanAmerican |
9.484800E-01 |
| Caucasian-vs-Asian |
2.234800E-01 |
| AfricanAmerican-vs-Asian |
3.086600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.0087999996754E-07 |
| Normal-vs-Female |
2.15849999996021E-06 |
| Male-vs-Female |
1.489690E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.02950000000035E-05 |
| Normal-vs-Age(41-60Yrs) |
6.65299999980107E-07 |
| Normal-vs-Age(61-80Yrs) |
7.18349999484502E-08 |
| Normal-vs-Age(81-100Yrs) |
5.645900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.611900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.29670000000604E-05 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.333000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.331900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.625000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.461000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.485900E-02 |
| Classical-VS-Follicular |
2.878300E-02 |
| Classical-VS-Other |
7.031000E-01 |
| Classical-VS-Normal |
3.61220000000273E-06 |
| Tall-VS-Follicular |
6.870600E-01 |
| Tall-VS-Other |
6.145200E-01 |
| Tall-VS-Normal |
3.22769999949735E-07 |
| Follicular-VS-Other |
6.935400E-01 |
| Follicular-VS-Normal |
2.44450000019825E-07 |
| Other-VS-Normal |
6.23589999999563E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.32610000039379E-07 |
| Normal-vs-N1 |
1.54746999999622E-05 |
| N0-vs-N1 |
6.965900E-02 |
|
|
